Tissue factor expression and multidrug resistance in cancer: two aspects of a common cellular response to a hostile milieu

被引:14
作者
Lwaleed, BA
Cooper, AJ
机构
[1] Univ Portsmouth, Dept Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England
[2] Southampton Univ Hosp, Dept Urol, MDR Res Grp, Southampton, Hants, England
[3] Southampton Univ Hosp, Dept Surg, MDR Res Grp, Southampton, Hants, England
关键词
D O I
10.1054/mehy.2000.1093
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tissue factor (TF) is the main physiological initiator of blood coagulation and its activation or de-encryption within plasma membranes is important for trapping, extravasation and angiogenesis in the development and spread of solid malignancies. Multidrug resistance is also an adaptive response in malignant (and normal) cells. It is often mediated by the over-expression of the P-glycoprotein (P-gP) efflux pump. Both TF and P-gP tend to be expressed together, perhaps as part of a coherent 'crisis management' response of cells to environmental change or challenge. An associated feature in such a response appears to be the reversal of normal phospholipid charge asymmetry in the plasma membrane bilayer. Responses to environmental stimuli affect function in normal and malignant tissue. Uniting the study of TF expression or de-encryption and MDR-1 phenotype would be biologically enlightening and might ultimately influence clinical cancer management and the control of thrombotic problems associated with treatment. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:470 / 473
页数:4
相关论文
共 40 条
[1]  
CALSEN E, 1987, TRANSPLANTATION, V43, P453
[2]   Role of tissue factor in embryonic blood vessel development [J].
Carmeliet, P ;
Mackman, N ;
Moons, L ;
Luther, T ;
Gressens, P ;
VanVlaenderen, I ;
Demunck, H ;
Kasper, M ;
Breier, G ;
Evrard, P ;
Muller, M ;
Risau, W ;
Edgington, T ;
Collen, D .
NATURE, 1996, 383 (6595) :73-75
[3]   Molecules in focus - Tissue factor [J].
Carmeliet, P ;
Collen, D .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1998, 30 (06) :661-667
[4]   URINARY TISSUE FACTOR ACTIVITY IN MALIGNANCY [J].
CARTY, N ;
TAYLOR, I ;
ROATH, OS ;
ELBARUNI, K ;
FRANCIS, JL .
THROMBOSIS RESEARCH, 1990, 57 (03) :473-478
[5]   High level expression of the multidrug resistance (MDRI) gene in the normal bladder urothelium: A potential involvement in protection against carcinogens? [J].
Clifford, SC ;
Neal, DE ;
Lunec, J .
CARCINOGENESIS, 1996, 17 (03) :601-604
[6]   In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease [J].
Contrino, J ;
Hair, G ;
Kreutzer, DL ;
Rickles, FR .
NATURE MEDICINE, 1996, 2 (02) :209-215
[7]  
CROSSMAN DC, 1990, J BIOL CHEM, V265, P9782
[8]   The role of passive transbilayer drug movement in multidrug resistance and its modulation [J].
Eytan, GD ;
Regev, R ;
Oren, G ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12897-12902
[9]  
Fenton James, 1996, Cytotechnology, V19, P264
[10]   MODULATION OF THE ORGAN MICROENVIRONMENT FOR TREATMENT OF CANCER METASTASIS [J].
FIDLER, IJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (21) :1588-1592